Hengyi Zhang

Hengyi Zhang

Auto-generated profile, based on publicly available information

Hengyi Zhang

SWUFE-UD Institute of Data Science, Southwestern University of Finance and Economics, Chengdu, China

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2024 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HZHengyi Zhang
Hengyi Zhang
WYWeihao Yang
Weihao Yang
XTXin Tan
Xin Tan
WHWenjun He
Wenjun He
LZLi-Ying Zhao
Li-Ying Zhao
Guoxin LiGuoxin Li
Guoxin Li
Gastric cancer poses a significant global health challenge. We aim to use period analysis to assess the changes in gastric cancer treatment at our center over the past 15 years. This study reflects the current state of gastric cancer treatment at our center and provides valuable data to support clinical advancements. We used period analysis to evaluate the survival status of 3915 patients with gastric cancer at Nanfang Hospital, Southern Medical University, over a 15-year period spaning from 2008 to 2022. The 5-year relative survival rates were analyzed. Our findings indicate that the 5-year relative survival rate at our center from 2018 to 2022 is 71.4%. From 2018 to 2022, the 5-year relative survival rates for patients aged < 40, 40–54, 55–69, and ≥ 70 reached 67.5%, 73.5%, 72.0%, and 67.1%, respectively. For stage IV patients, the 5-year relative survival rate reached 29% in 2018–2022. For stage I-III patients, the 5-year relative survival rate reached 89.7% in 2018–2022. The five-year relative survival rate for patients who underwent laparoscopic surgery at our center rose from 50.3% in 2008–2012 to 71.4% in 2018–2022. Overall, there has been a notable increase in the 5-year relative survival rates, regardless of age, gender, region, or tumor stage. Period analysis over the past 15 years shows significant improvement in the 5-year survival rate for gastric cancer at our center. This progress is due to standardized surgical techniques, perioperative management, and immunotherapy, providing robust data for evaluating the efficacy of recent treatments.

6 July 2009 in Frontiers of Chemistry in China
Verified
Journal Article
Closed access
PDF file
WJWei Jiang
Wei Jiang
HZHengyi Zhang
Hengyi Zhang
YLYu Liu
Yu Liu

27 September 2000 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
YLYu Liu
Yu Liu
HZHeng-Yi Zhang
Heng-Yi Zhang
XBXiao-Peng Bai
Xiao-Peng Bai
TWTakehiko WADA
Takehiko WADA
YIYoshihisa Inoue
Yoshihisa Inoue

14 May 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
JCJunkai Cheng
Junkai Cheng
YZYijia Zhang
Yijia Zhang
HZHengyi Zhang
Hengyi Zhang
SJShaoxiong Ji
Shaoxiong Ji
MLMingyu Lu
Mingyu Lu
Predicting drug-drug interaction (DDI) plays a crucial role in drug recommendation and discovery. However, wet lab methods are prohibitively expensive and time-consuming due to drug interactions. In recent years, deep learning methods have gained widespread use in drug reasoning. Although these methods have demonstrated effectiveness, they can only predict the interaction between a drug pair and do not contain any other information. However, DDI is greatly affected by various other biomedical factors (such as the dose of the drug). As a result, it is challenging to apply them to more complex and meaningful reasoning tasks. Therefore, this study regards DDI as a link prediction problem on knowledge graphs and proposes a DDI prediction model based on Cross-Transformer and Graph Convolutional Networks (GCN) in first-order logical query form, TransFOL. In the model, a biomedical query graph is first built to learn the embedding representation. Subsequently, an enhancement module is designed to aggregate the semantics of entities and relations. Cross-Transformer is used for encoding to obtain semantic information between nodes, and GCN is used to gather neighbour information further and predict inference results. To evaluate the performance of TransFOL on common DDI tasks, we conduct experiments on two benchmark datasets. The experimental results indicate that our model outperforms state-of-the-art methods on traditional DDI tasks. Additionally, we introduce different biomedical information in the other two experiments to make the settings more realistic. Experimental results verify the strong drug reasoning ability and generalization of TransFOL in complex settings. Data and code are available at https://github.com/Cheng0829/TransFOL .

13 September 2021 in Journal of Russian Laser Research
Verified
Journal Article
Closed access
PDF file
BHBingyuan Han
Bingyuan Han
YXYawei Xu
Yawei Xu
KZKebing Zhou
Kebing Zhou
WLWeining Lei
Weining Lei
XLXiaoping Li
Xiaoping Li
HZHengyi Zhang
Hengyi Zhang

28 October 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
JCJunkai Cheng
Junkai Cheng
YZYijia Zhang
Yijia Zhang
HZHengyi Zhang
Hengyi Zhang
YPYifan Peng
Yifan Peng
MLMingyu Lu
Mingyu Lu
Synthetic lethality (SL) has emerged as a promising strategy in cancer medicine. However, complex biomolecular interactions make wet lab methods time-consuming and expensive. Machine learning methods have gained widespread adoption for SL prediction in recent years. Although these methods have demonstrated particular effectiveness, they suffer from weak interpretability, making it difficult for users to understand the specific reasoning processes of the models. Also, they typically focus on a simple gene pair, thus struggling with more meaningful reasoning tasks involving other medical factors as in real life. To address these gaps, we propose an explainable multi-hop reasoning model EFOL-SL based on first-order logic queries. We first construct query graphs with triplet transformations for different tasks. Node embeddings are then fed into a sparse Transformer encoder and a visualized graph attention decoder to generate comprehensive multi-hop logical reasoning chains. By masking nodes in intermediate reasoning steps, our model can explicitly predict each node, allowing observation of its exact reasoning process. Additionally, we conduct extensive experiments on two widely used benchmarks with complex SL prediction tasks involving diverse medical entities. Evaluations demonstrate superior performance of our model over state-of-the-art methods on various tasks. Notably, EFOL-SL provides specific multi-hop logical reasoning chains behind its predictions, offering meaningful insights into the model's reasoning process.